Rudolf Kwan

Rudolf Kwan

Corporate Officer/Principal chez National Institute on Drug Abuse

71 ans
Health Technology
Consumer Services
Government

Profil

Rudolf Kwan is currently the Chairman of the Data Monitoring & Safety Board at the National Institute on Drug Abuse and a Member of The Royal College of Physicians.
He previously worked as the Vice President of Global Clinical Development at Chiron Corp.
and GlaxoSmithKline LLC, and as the VP & Head of Asia Pacific Global Clinical Operations at Schering-Plough Corp.
From 2008 to 2022, he served as the Chief Medical Officer at Athenex, Inc. Dr. Kwan received his undergraduate degree from the University of Hong Kong.

Postes actifs de Rudolf Kwan

SociétésPosteDébut
National Institute on Drug Abuse Corporate Officer/Principal -
The Royal College of Physicians Corporate Officer/Principal -
Tous les postes actifs de Rudolf Kwan

Anciens postes connus de Rudolf Kwan

SociétésPosteFin
ATHENEXPAR Chief Tech/Sci/R&D Officer 08/06/2022
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Rudolf Kwan

Formation de Rudolf Kwan

University of Hong Kong Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Rudolf Kwan

Relations

100 +

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées5

Health Technology

Health Technology

Health Technology

National Institute on Drug Abuse

Government

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Rudolf Kwan